Daily Briefing

Ezekiel Emanuel: Why men are more likely to die from Covid-19 than women


According to CDC data, men are more likely than women to experience worse outcomes from Covid-19, including more severe symptoms and death—but the reason why is unclear. Writing for the New York Times, Ezekiel Emanuel, the vice provost of global initiatives and a professor of medical ethics and health policy at the University of Pennsylvania, explains some potential factors behind this disparity, and why more research is needed to explore these sex differences.

Radio Advisory episode: Ezekiel Emanuel on the path to a vaccine (and why it's much harder than you think)

Men face worse Covid-19 outcomes than women

According to Emanuel, there are significant sex differences when it comes to Covid-19 outcomes, with men faring worse than women on several different measures.

For example, men are more likely experience severe effects of Covid-19. A study published in PLoS One found that male Covid-19 patients had an almost 50% higher rate of respiratory intubation and a 22% longer hospital stay than female Covid-19 patients.

Men are also more likely to die from Covid-19 than women, a disparity which Emanuel writes has existed "since early in the pandemic, before there were any vaccines."

According to CDC data, women currently make up 45.6% of Covid-19 deaths in the United States, while men, who make up slightly less than half of the U.S. population, account for 54.4% of Covid deaths. This difference widens even further among Americans ages 65 to 84, who are at the highest risk of severe Covid-19, Emanuel writes. Among this group, 57.9% of Covid-19 deaths have occurred in men, compared to 42.1% in women. Overall, the Brookings Institution estimates that at least 65,000 more men in the United States have died from Covid-19 than women.

In addition, Emanuel writes that there may be differences in how men and women respond to Covid-19 vaccines. In particular, men may be more likely to develop certain rare complications after Covid-19 vaccination than women. A study from Israel examining the effects of the Pfizer-BioNTech Covid-19 vaccine that the rate of myocarditis, an inflammation of the heart muscle, was almost 18 times higher in men than women ages 16 and older.

There is also evidence suggesting that immunity from vaccination wanes more quickly in men than women. Another study from Israel found that antibody levels were "substantially lower among men than women" six months after the second dose of Pfizer-BioNTech's vaccine. Among vaccinated men age 65 and older, certain antibody levels were 46% lower than vaccinated women of the same age.

The potential reasons behind the disparity

Why men experience worse Covid-19 outcomes than women is "mostly a mystery," Emanuel writes, but researchers have posited several possible explanations.

According to Emanuel, some researchers believe that higher Covid-19 death rates are largely due to lower vaccination rates. In the United States, just over 50% of men are fully vaccinated, but 55% of women are fully vaccinated. However, Emanuel notes that vaccination cannot account for all these Covid-19 disparities, since many of them were observed even before the vaccines were available.

Other researchers have suggested that factors such as work, mask wearing, or underlying health conditions may play a role in the differences between men and women. For example, in China, men's higher smoking rates may have caused them to experience more severe Covid-19 outcomes.

There are also potential biological explanations for the differences between men and women, Emanuel writes. In an article published in Nature, researchers from Yale University noted that there are well-established differences in men's immune responses to infections when compared with women. The same researchers found differences in men's and women's responses to Covid-19, finding that men had higher blood levels of inflammatory proteins that regulate immune responses, which could have led to "an overexuberant immune response to the coronavirus," Emanuel writes.

In addition, hormones may play a role in how men and women respond to the coronavirus. Testosterone may dampen men's immune response, leading to more severe Covid-19. Estrogen, on the other hand, may be why women have more antibody-producing B cells and may inhibit immune cells that cause myocarditis.

Although an exact cause of the disparity in Covid-19 outcomes is still unknown, Emanuel writes that "[t]he medical community needs to be more open to exploring sex differences in disease."

He adds, "One way to respond to the Covid-19 death-rate disparity now is to target men for vaccines and boosters."

Overall, Emanuel encourages more research into the higher rate of Covid-19 deaths, complications, and waning immunity among men. "Rigorously looking at the differences in Covid-19's toll and discovering the underlying causes is imperative to better understanding this disease—as well as other infectious diseases—and how to treat it," he writes. (Emanuel, New York Times, 11/2)


Zeke Emanuel on the path to a vaccine

(and why it's much harder than you think)

Radio Advisory, a podcast for busy health care leaders.

To date, much of the news reporting on the path to a Covid-19 vaccine has focused on the development of the vaccine itself. But as Ezekiel Emanuel writes, finding a viable vaccine is just one of 22 steps that he argues the federal government and congress must make immediately. In this episode, Rachel (Rae) invites Zeke to discuss the challenges ahead, and shares why manufacturing and distributing an effective Covid-19 vaccine is something every leader in health care should start planning for now.


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.